MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Change in fair value ofderivatives$8,525K (-42.90%↓ Y/Y)Change in fair value ofcontingent earnout...-$4,732K (90.48%↑ Y/Y)Interest income$330K (-50.15%↓ Y/Y)Net (loss) incomeand comprehensive...-$17,619K (-145.02%↓ Y/Y)Total other income,net$11,316K (-81.84%↓ Y/Y)Product$493K (235.37%↑ Y/Y)Product And ServiceOther$2K (-99.46%↓ Y/Y)Interest expense$2,271K (-24.30%↓ Y/Y)Loss from operations-$28,935K (-24.81%↓ Y/Y)Revenue$495K (-4.26%↓ Y/Y)Total operatingexpenses$29,430K (24.17%↑ Y/Y)Research and development$19,462K (26.23%↑ Y/Y)General andadministrative$7,930K Cost of goods sold$2,038K (1286.39%↑ Y/Y)
Income Statement
source: myfinsight.com

Humacyte, Inc. (HUMA)

Humacyte, Inc. (HUMA)